内皮病与机械通气撤机延迟相关:一项队列研究
这项前瞻性单中心队列研究纳入459例入ICU时接受机械通气的成人急性呼吸衰竭患者,检测入ICU时血浆Syndecan-1、可溶性血栓调节蛋白(sTM)和血小板内皮细胞黏附分子-1(PECAM-1)水平。主要终点为撤机率(与机械通气期间死亡竞争风险同时报告)。sTM升高与撤机率更低相关(校正HR 0.71,25th至75th百分位增加,95%CI 0.54-0.93,p=0.01);PECAM-1升高仅在最初5天与撤机率更低相关(校正HR 0.72,95%CI 0.58-0.9,p<0.01)。Syndecan-1和PECAM-1升高与机械通气期间死亡风险更高相关;所有生物标志物升高均与30天全因死亡率更高相关。
要点
- 入ICU时sTM升高与撤机率更低独立相关(校正HR 0.71,25th至75th百分位增加,95%CI 0.54-0.93,p=0.01)。
- 入ICU时PECAM-1升高仅在最初5天与撤机率更低相关(校正HR 0.72,95%CI 0.58-0.9,p<0.01)。
- Syndecan-1和PECAM-1升高与机械通气期间死亡风险更高相关。
- sTM和PECAM-1与入ICU时PaO2/FiO2比值负相关;无生物标志物与末次PaO2/FiO2比值相关。
- 所有生物标志物升高均与30天全因死亡率更高相关。
适用人群与场景
- 入ICU时接受机械通气的成人急性呼吸衰竭患者,共459例。
研究设计与关键结果
- 研究类型:前瞻性单中心队列研究,纳入459例入ICU时机械通气的成人急性呼吸衰竭患者。
- 主要终点:撤机率(与机械通气期间死亡竞争风险同时报告);sTM升高与撤机率更低相关(校正HR 0.71,25th至75th百分位增加,95%CI 0.54-0.93,p=0.01)。
- PECAM-1升高与撤机率更低相关,但仅限最初5天(校正HR 0.72,25th至75th百分位增加,95%CI 0.58-0.9,p<0.01)。
- Syndecan-1和PECAM-1升高与机械通气期间死亡风险更高相关。
- sTM和PECAM-1与入ICU时PaO2/FiO2比值负相关;无生物标志物与末次PaO2/FiO2比值相关。
- 所有生物标志物升高均与30天全因死亡率更高相关。
- Cox回归校正因素:性别、年龄、慢性阻塞性肺疾病、脓毒性休克、心力衰竭、入ICU时PaO2/FiO2比值、呼吸道感染、急性肾损伤、胆红素。
- PaO2/FiO2比值线性回归校正因素:年龄、慢性阻塞性肺疾病、呼吸道感染、休克。
证据类型、等级与局限
- 证据类型:前瞻性单中心队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在急性呼吸衰竭机械通气患者中,入ICU时检测内皮病生物标志物(Syndecan-1、sTM、PECAM-1)可能有助于识别撤机延迟和死亡风险更高的患者。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Endotheliopathy is suggested as pivotal pathophysiology of sepsis and trauma-associated organ failure, but its role in acute respiratory failure is not yet determined. We investigated if endotheliopathy biomarkers at ICU admission are associated with illness severity and clinical outcomes in patients with acute respiratory failure requiring mechanical ventilation.
METHODS: We conducted a prospective single-center cohort study including 459 mechanically ventilated adults at ICU admission. Plasma levels of three endotheliopathy biomarkers were measured at ICU admission: Syndecan-1, soluble Thrombomodulin (sTM), and Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1). The primary outcome was the rate of liberation from mechanical ventilation, which is presented together with the rate of the competing risk of death while still on mechanical ventilation. Secondary outcomes were PaO2/FiO2-ratios on admission and on last measurement in patients dying within five days, and 30-day all-cause mortality. The primary outcome and 30-day all-cause mortality were analyzed using Cox regression, controlled for gender, age, chronic obstructive pulmonary disease, septic shock, heart failure, PaO2/FiO2-ratio at admission, respiratory infection, acute kidney injury, and bilirubin. PaO2/FiO2-ratios were analyzed using linear regression, controlled for age, chronic obstructive pulmonary disease, respiratory infection, and shock.
RESULTS: Patients with high sTM were liberated from mechanical ventilation at a lower rate (adjusted hazard ratio (HR) 0.71, for an increase from the 25th to the 75th percentile, 95% confidence interval (CI) 0.54-0.93, p = 0.01). Patients with high PECAM-1 were liberated from mechanical ventilation at a lower rate, but only during the first 5 days (adjusted HR 0.72, for an increase from the 25th to the 75th percentile, 95% CI 0.58-0.9, p < 0.01). High levels of Syndecan-1 and PECAM-1 were associated with a higher rate of death while still on mechanical ventilation. sTM and PECAM-1 were negatively associated with PaO2/FiO2-ratio at ICU admission and no biomarker was associated with last measured PaO2/FiO2-ratio. High levels of all biomarkers were associated with higher 30-day all-cause mortality.
CONCLUSION: In acute respiratory failure, endotheliopathy biomarkers are associated with lower rates of liberation from mechanical ventilation, hypoxemia at ICU admission, and 30-day all-cause mortality.
参考来源
- Schønemann-Lund M, Itenov TS, Larsson JE, et al. Endotheliopathy is associated with slower liberation from mechanical ventilation: a cohort study. Crit Care. 2022. PMID: 35094711. doi:10.1186/s13054-021-03877-y
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。